NIH wants gender trial parity

Share this article:

The National Institutes of Health wants clinical trial researchers to start recruiting female lab animals. The New York Times reports that the NIH warned scientists that they can no longer avoid having to cope with reproductive cycles and hormone fluctuations.

The NYT notes that it has taken a long time to raise the number of women participating in human clinical trials, and that men continue to dominate trial populations.

The NYT also notes that statins were mostly tested in men, and “evidence of their benefit in women is limited.”

“One of the underlying assumptions has been that females are simply a variation on a theme, that it isn't a fundamentally different mechanism. . . we've discovered that's not always the case,” a University of Michigan research scientist told the Times.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.